Tissueblue
Payments companies reported to CMS as associated with Tissueblue. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tissueblue, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tissueblue
These are the largest totals companies reported as associated with Tissueblue. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Almeida | Erie, PA | Ophthalmology | $28,909.64 |
| Asheesh Tewari | Dearborn, MI | Retina Specialist | $24,511.50 |
| Gaurav Shah | San Francisco, CA | Ophthalmology | $23,757.49 |
| Christopher Riemann | Cincinnati, OH | Ophthalmology | $13,651.20 |
| Dilraj Grewal | Chicago, IL | Ophthalmology | $12,534.11 |
| Colin Mccannel | Los Angeles, CA | Ophthalmology | $11,074.42 |
| Jorge Fortun | Palm Beach Gardens, FL | Ophthalmology | $10,897.61 |
| Lejla Vajzovic | Durham, NC | Ophthalmology | $9,925.72 |
| Courtney Crawford | Burleson, TX | Retina Specialist | $8,395.21 |
| Audina Berrocal | Miami, FL | Retina Specialist | $7,115.27 |
Prescribed Tissueblue?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.